Jane Street Group, LLC Tcr2 Therapeutics Inc. Call Options Transaction History

Jane Street Group, LLC

  • $72.9 Billion
  • Q1 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$16.41 - $24.71 $557,940 - $840,140
-34,000 Reduced 48.57%
36,000 $591,000
Q1 2021

May 18, 2021
BUY
$20.38 - $34.07 $884,492 - $1.48 Million
43,400 Added 163.16%
70,000 $1.55 Million
Q4 2020

Feb 17, 2021
BUY
$19.0 - $32.63 $505,400 - $867,958
26,600 New
26,600 $823,000

About TCR2 THERAPEUTICS INC.

TCRR Quotes by TradingView
  • Ticker TCRR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,606,400
  • Description
  • TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...
More about TCRR
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email